INTERPACE BIOSCIENCES, INC. Quarterly Cost of Revenue in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Interpace Biosciences, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2014 to Q3 2024.
  • Interpace Biosciences, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $4.79M, a 16.1% increase year-over-year.
  • Interpace Biosciences, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $17.7M, a 14.6% increase year-over-year.
  • Interpace Biosciences, Inc. annual Cost of Revenue for 2023 was $16.3M, a 19.9% increase from 2022.
  • Interpace Biosciences, Inc. annual Cost of Revenue for 2022 was $13.6M, a 4.94% decline from 2021.
  • Interpace Biosciences, Inc. annual Cost of Revenue for 2021 was $14.3M, a 34% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $17.7M $4.79M +$665K +16.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $17.1M $4.61M +$420K +10% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $16.7M $4.2M +$354K +9.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $16.3M $4.15M +$827K +24.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $15.5M $4.12M +$667K +19.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $14.8M $4.19M +$626K +17.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $14.2M $3.85M +$583K +17.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $13.6M $3.32M +$3.74M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $9.87M $3.46M -$163K -4.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $10M $3.57M -$2.24M -38.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $12.3M $3.27M -$2.05M -38.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $14.3M -$422K -$6.94M -106% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $21.3M $3.62M -$1.57M -30.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $22.8M $5.8M +$1.95M +50.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $20.9M $5.32M -$797K -13% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $21.7M $6.52M +$1.12M +20.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $20.6M $5.19M +$359K +7.43% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $20.2M $3.85M +$819K +27% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $19.4M $6.11M +$3.49M +133% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $15.9M $5.4M +$2.79M +107% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 $13.1M $4.84M +$2.07M +75% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-20
Q2 2019 $11M $3.03M +$784K +34.9% Apr 1, 2019 Jun 30, 2019 10-Q/A 2021-01-19
Q1 2019 $10.2M $2.62M +$42K +1.63% Jan 1, 2019 Mar 31, 2019 10-Q/A 2021-01-19
Q4 2018 $10.2M $2.61M +$968K +59.1% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
Q3 2018 $9.23M $2.76M +$694K +33.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $8.54M $2.25M +$368K +19.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $8.17M $2.58M +$809K +45.7% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $7.36M $1.64M -$135K -7.61% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-23
Q3 2017 $7.49M $2.07M +$223K +12.1% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $7.27M $1.88M +$37K +2.01% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $7.23M $1.77M +$592K +50.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $6.64M $1.77M +$88K +5.22% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 $6.55M $1.85M +$47K +2.61% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $6.51M $1.84M -$9K -0.49% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $6.52M $1.18M -$395K -25.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 $6.91M $1.69M +$77.4M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$70.4M $1.8M -$22.6M -92.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-17
Q2 2015 -$47.8M $1.85M -$24M -92.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$23.9M $1.57M -$25.1M -94.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $1.27M -$75.7M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $24.4M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $25.8M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $26.7M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.